Buildings and Facilities. 2.2.1 Will FORMULATE, PACKAGE and store the PRODUCT at the following addresses ("SITES"): ENTOCORT EC Capsules: Formulation- AstraZeneca LP ▇-▇▇▇ ▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇ Packaging- AstraZeneca Pharmaceuticals LP ▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ X 2.2.2 Will ensure that any buildings and building systems (for example, lighting, ventilation, water, etc.) used in FORMULATION and PACKAGING of PRODUCT will be of suitable design, size, construction and location to manufacture PRODUCT in accordance with applicable Laws (e.g., cGMP). X 2.2.3 Will store and warehouse the PRODUCT in the SITE(S) located at the following address: Integrated Commercialization Solutions ("ICS") ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ X
Appears in 2 contracts
Sources: Distribution Agreement (Prometheus Laboratories Inc), Distribution Agreement (Prometheus Laboratories Inc)